Home >> Professional Blog

MiMedx Announces Record Results for Second Quarter of 2015

MiMedx BuildingMiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced its record results for the second quarter of 2015.

Highlights of Second Quarter 2015 include:
      * Q2 2015 is 15th consecutive quarter of meeting or exceeding Company revenue guidance
      * Q2 2015 revenue of $45.7 million increased 79% over Q2 2014
      * Revenue is at the upper end of Company Q2 guidance
      * Q2 2015 Wound Care sales grew 73% over Q2 2014
      * Q2 2015 Surgical, Sports Medicine/Orthopedic revenue increased 104% over Q2 2014
      * Adjusted EBITDA* of $10.6 million represents a 265% improvement over Q2 2014
      * Q2 2015 net income of $5.4 million or $0.05 per diluted share vs Q2 2014 net loss of $390,000 or $0.00 per diluted share

Read the full article